Cargando…

The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain

Pain is a subjective, private, yet universal phenomenon that depends on a unique combination of sensory, affective, and evaluative characteristics. Although preclinical models have been used to understand much of pain physiology, the inability to communicate with animals limits affective and evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Salcido, Celina A., Argenbright, Cassie M., Aguirre, Tiffany, Trujillo, Alex D., Fuchs, Perry N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915719/
https://www.ncbi.nlm.nih.gov/pubmed/35295429
http://dx.doi.org/10.3389/fpain.2021.793958
_version_ 1784668106172399616
author Salcido, Celina A.
Argenbright, Cassie M.
Aguirre, Tiffany
Trujillo, Alex D.
Fuchs, Perry N.
author_facet Salcido, Celina A.
Argenbright, Cassie M.
Aguirre, Tiffany
Trujillo, Alex D.
Fuchs, Perry N.
author_sort Salcido, Celina A.
collection PubMed
description Pain is a subjective, private, yet universal phenomenon that depends on a unique combination of sensory, affective, and evaluative characteristics. Although preclinical models have been used to understand much of pain physiology, the inability to communicate with animals limits affective and evaluative feedback and has constrained traditional behavioral methods to adequately represent and study the multidimensional pain experience. Therefore, this study sought to characterize the affective component of pain within a novel operant approach-avoidance paradigm (AAP) to determine which type of pain (inflammatory and neuropathic) may be more aversive. To reveal the possible differences in pain aversiveness within the AAP paradigm, animals received bilateral inflammatory and neuropathic pain conditions and were given the choice to a) forgo appetitive reward by not receiving noxious stimulus of either inflammatory or neuropathic conditions or b) receive noxious stimulus in exchange for an appetitive reward. Although all pain conditions produced significant hypersensitivity, the AAP results revealed there was no preference in the stimulation of a specific paw in the bilateral pain conditions. The finding suggests that despite unique clinical pain characteristics for inflammatory and neuropathic conditions, the lack of observable differences in the pain conditions may not necessarily equate to the overall similarity in aversiveness, but rather that the fixed ratio (FR1) paradigm presentation allowed appetitive reward to be more salient, highlighting the complexities of competing motivational drives of pain and hunger when satiating hunger is always guaranteed. Thus, future studies should seek to further tease apart this relationship with a different schedule and food-controlled methodologies. The development of such preclinical approaches can thoroughly investigate the intricacy of competing drives and likely reveal important information regarding the complexity of pain, enhancing our understanding of pain perception in individuals suffering from comorbid pain states.
format Online
Article
Text
id pubmed-8915719
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89157192022-03-15 The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain Salcido, Celina A. Argenbright, Cassie M. Aguirre, Tiffany Trujillo, Alex D. Fuchs, Perry N. Front Pain Res (Lausanne) Pain Research Pain is a subjective, private, yet universal phenomenon that depends on a unique combination of sensory, affective, and evaluative characteristics. Although preclinical models have been used to understand much of pain physiology, the inability to communicate with animals limits affective and evaluative feedback and has constrained traditional behavioral methods to adequately represent and study the multidimensional pain experience. Therefore, this study sought to characterize the affective component of pain within a novel operant approach-avoidance paradigm (AAP) to determine which type of pain (inflammatory and neuropathic) may be more aversive. To reveal the possible differences in pain aversiveness within the AAP paradigm, animals received bilateral inflammatory and neuropathic pain conditions and were given the choice to a) forgo appetitive reward by not receiving noxious stimulus of either inflammatory or neuropathic conditions or b) receive noxious stimulus in exchange for an appetitive reward. Although all pain conditions produced significant hypersensitivity, the AAP results revealed there was no preference in the stimulation of a specific paw in the bilateral pain conditions. The finding suggests that despite unique clinical pain characteristics for inflammatory and neuropathic conditions, the lack of observable differences in the pain conditions may not necessarily equate to the overall similarity in aversiveness, but rather that the fixed ratio (FR1) paradigm presentation allowed appetitive reward to be more salient, highlighting the complexities of competing motivational drives of pain and hunger when satiating hunger is always guaranteed. Thus, future studies should seek to further tease apart this relationship with a different schedule and food-controlled methodologies. The development of such preclinical approaches can thoroughly investigate the intricacy of competing drives and likely reveal important information regarding the complexity of pain, enhancing our understanding of pain perception in individuals suffering from comorbid pain states. Frontiers Media S.A. 2022-01-20 /pmc/articles/PMC8915719/ /pubmed/35295429 http://dx.doi.org/10.3389/fpain.2021.793958 Text en Copyright © 2022 Salcido, Argenbright, Aguirre, Trujillo and Fuchs. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pain Research
Salcido, Celina A.
Argenbright, Cassie M.
Aguirre, Tiffany
Trujillo, Alex D.
Fuchs, Perry N.
The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain
title The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain
title_full The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain
title_fullStr The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain
title_full_unstemmed The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain
title_short The Use of an FR1 Schedule Operant Approach-Avoidance Paradigm to Measure the Aversiveness of Neuropathic and Inflammatory Pain
title_sort use of an fr1 schedule operant approach-avoidance paradigm to measure the aversiveness of neuropathic and inflammatory pain
topic Pain Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915719/
https://www.ncbi.nlm.nih.gov/pubmed/35295429
http://dx.doi.org/10.3389/fpain.2021.793958
work_keys_str_mv AT salcidocelinaa theuseofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT argenbrightcassiem theuseofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT aguirretiffany theuseofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT trujilloalexd theuseofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT fuchsperryn theuseofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT salcidocelinaa useofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT argenbrightcassiem useofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT aguirretiffany useofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT trujilloalexd useofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain
AT fuchsperryn useofanfr1scheduleoperantapproachavoidanceparadigmtomeasuretheaversivenessofneuropathicandinflammatorypain